Detalhe da pesquisa
1.
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
J Viral Hepat
; 31(4): 197-207, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38243144
2.
Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Am J Gastroenterol
; 2023 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37561058
3.
Getting to HBV cure: The promising paths forward.
Hepatology
; 76(1): 233-250, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34990029
4.
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.
Liver Int
; 43(1): 77-89, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36300646
5.
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
J Hepatol
; 77(3): 642-652, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35460726
6.
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
J Hepatol
; 77(5): 1265-1275, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35697332
7.
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B.
J Viral Hepat
; 29(11): 986-993, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36048970
8.
Ribavirin Does Not Enhance Hepatitis B Virus Nucleotide Antiviral Activity: A Pilot Study.
Clin Invest Med
; 45(4): E11-15, 2022 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36586101
9.
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.
J Viral Hepat
; 28(1): 51-60, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32896948
10.
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study.
J Viral Hepat
; 28(6): 942-950, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33749086
11.
Distinct Hepatitis B and HIV co-infected populations in Canada.
J Viral Hepat
; 28(3): 517-527, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33306853
12.
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Gastroenterology
; 157(1): 227-241.e7, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30930022
13.
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).
Gut
; 68(12): 2206-2213, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31462554
14.
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.
Liver Int
; 39(8): 1418-1427, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30912219
15.
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Dig Dis Sci
; 64(1): 285-286, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30324553
16.
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B.
J Hepatol
; 68(3): 431-440, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29104121
17.
96â¯weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
J Hepatol
; 68(4): 672-681, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29756595
18.
Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.
Clin Gastroenterol Hepatol
; 2018 Jun 20.
Artigo
Inglês
| MEDLINE | ID: mdl-29933096
19.
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
Dig Dis Sci
; 63(12): 3487-3497, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30136045
20.
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study.
J Hepatol
; 66(1): 11-18, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27545497